In order to ensure the highest scientific quality of joint clinical assessment reports, Articles 8(6) and 11(4) of Regulation (EU) 2021/2282 provide for the involvement of patients, clinical experts and other relevant experts in joint clinical assessments. Under Article 25(1), point (b), of Regulation (EU) 2021/2282, the Commission is to adopt, after consulting all relevant stakeholders, general procedural rules on the selection and consultation of stakeholder organisations and patients, clinical experts and other relevant experts in joint clinical assessments at Union level. Based on these rules, the Coordination Group, pursuant to Article 3(7), point (j), of Regulation (EU) 2021/2282, is to ensure appropriate involvement of stakeholder organisations and experts in its work.
Recital 4, Regulation (EU) 2024/1381
In forcesince 23 May 2024